Cesini, Laura <br/><br/>
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia.  [electronic resource] 

 -  European journal of haematology  Sep 2020 
 - 286-291 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1600-0609 
<br/><br/><label>Standard No.: </label>10.1111/ejh.13436  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anemia--blood<br/>Antineoplastic Agents--adverse effects<br/>Biomarkers<br/>Disease Management<br/>Disease Susceptibility<br/>Erythrocyte Indices<br/>Erythropoietin--administration & dosage<br/>Female<br/>Humans<br/>Imatinib Mesylate--adverse effects<br/>Leukemia, Myeloid, Chronic-Phase--complications<br/>Male<br/>Middle Aged<br/>Protein Kinase Inhibitors--adverse effects<br/>Treatment Outcome